Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
- 1 September 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (3), 853-862
- https://doi.org/10.1016/s0002-9440(10)65184-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998
- Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid AngiopathyStroke, 1996
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsJournal of Biological Chemistry, 1996
- Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative StressExperimental Neurology, 1995
- Searching for the holy grail: What is the structural correlate of cognition?Neurobiology of Aging, 1995
- Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404Journal of Neuroscience Research, 1994
- The Seminal Role of β-Amyloid in the Pathogenesis of Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented personNeuroscience Letters, 1990
- The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly SubjectsThe British Journal of Psychiatry, 1968